3SBio company profile

1530 · HKEX · HKD

Compare 3SBio
$12.71Change from previous close: −3.64%Absolute change: −$0.48

Close · November 20, 2026

Company profile

3SBio has 6,068 employees and is headquartered in Shenyang, China.

TPIAO, EPIAO, Yisaipu, Cipterbin and Mandi are the names people most associate with 3SBio Inc. Its biopharmaceutical portfolio addresses low platelet counts, anemia linked to chronic kidney disease, rheumatoid arthritis, psoriasis, breast cancer and hair loss. Beyond drug development and production, the group sells pharmaceuticals, operates pharmaceutical retail, and provides clinic, technology, agricultural and consulting services. Its activities reach the Chinese market, the United States and other countries.

In the fiscal year ended December 2025, 3SBio reported revenue of 17.7 billion yuan, up 94.3% from the previous year, and net profit of 8.5 billion yuan. The company had 6,068 employees and is headquartered in Shenyang, in the People's Republic of China, where it was founded in 1993.

Company facts

Industry
Biotechnology
Headquarters
No. 3 A1, Road 10, Shenyang
Employees
6,068
Chief executive
Jing Lou
Founded
1993
Fiscal year
January - December
Listing
1530 · HKEX
Currency
HKD
ISIN
KYG8875G1029
Website
3sbio.com

3SBio and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
3SBio1530Hong Kong SAR China$4.56B6,06860.3%3.90
Akeso9926Hong Kong SAR China$6.81B4,082-30.7%—
Telix PharmaceuticalsTLXAustralia$2.92B1,1206.2%92.3
InSilico Medicine Cayman TopCo3696Hong Kong SAR China$2.59B333-6.9%—
Genscript Biotech1548Hong Kong SAR China$8.77B6,13514.9%—
Haisco Pharmaceutical Group002653China$8.97B5,59721.1%44.1

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare 3SBio with its competitors